Abstract
This article provides an overview of the use of intrathecal baclofen in the treatment of spasticity due to cerebral origin. Oral and intrathecal uses of baclofen are compared. The unique pharmacological properties of baclofen which make it ideal for intrathecal use are discussed.. Historical development of the treatment in both spinal and cerebral spasticity is presented. Technical aspects (performing trials, surgical insertion, and maintenance) and complications of treatment are reviewed. Through the use of case studies selection of candidates and concomitant treatment options are explored
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
